Latest Content

After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature through powerful advocacy.

Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions.

Dr. W. Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual disease

Meet Dr. Susan MacDonald, a urologist with stage 4 breast cancer who is the host of CURE's new vlog series, "Demystifying the Darkness."

Emactuzumab improved tumor response and function in TGCT, showing rapid, durable benefits in a phase 3 trial with a short-course treatment approach.

Dr. Costas Bizekis discusses how minimally invasive surgery is improving recovery, reducing complications and enhancing outcomes in esophageal cancer.

Stage 1 urothelial carcinoma is highly treatable; learn about diagnosis, treatment options and how to reduce recurrence risk through ongoing monitoring.

Meetings like SGO drive collaboration and patient-centered progress, as Dr. Ginger J. Gardner highlights their role in advancing access and research.

Persistent heartburn may signal more than GERD. Learn how reflux can lead to Barrett’s esophagus and increase esophageal cancer risk.

Rezatapopt shows activity in TP53-mutated ovarian cancer, with responses seen across heavily pretreated patient groups and manageable side effects.

Daraxonrasib improved overall survival versus chemotherapy in metastatic pancreatic cancer.

A leukemia survivor shares how her experience inspired a national support network for young adults navigating cancer and survivorship.

Dr. Kemi Doll reports that peer support helped Black women with high-risk endometrial cancer complete treatment in the SISTER trial.